Jean-Marc Balloul
15Patents
5h-index
19Co-inventors
63Inventor score
Filing activity: Feb 19, 1992 → Feb 25, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6884786B1 | Antitumoral composition based on immunogenic polypeptide with modified cell location | Chemistry; Metallurgy | 22 | Expired |
| US7488482B2 | Pharmaceutical compositions for treating papillomavirus tumors and infection | Chemistry; Metallurgy | 15 | Active |
| US7118754B1 | Pharmaceutical composition for treating papillomavirus tumors and infection | Chemistry; Metallurgy | 10 | Expired |
| US8420103B2 | Papillomavirus vaccines | Chemistry; Metallurgy | 6 | Active |
| US5597570A | Protein recognized by antibodies raised against native P28 of schistosoma mansoni | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7670607B2 | Pharmaceutical compositions for treating papillomavirus tumors and infection | Chemistry; Metallurgy | 3 | Active |
| US7332478B2 | Antitumoral composition based on immunogenic polypeptide with modified cell location | Chemistry; Metallurgy | 2 | Expired |
| US5279822A | Monoclonal antibodies against the 28KD protein of S. mansoni | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5753236A | Antigenic composition obtained by V8 proteolysis of a protein from S. mansoni | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7348014B2 | Poxvirus with targeted infection specificity | Chemistry; Metallurgy | 0 | Expired |
| US7354591B2 | Poxvirus with targeted infection specificity | Chemistry; Metallurgy | 0 | Expired |
| US8932599B2 | Synthetic gene construct coding for an HIV1 GAG and use thereof for obtaining anti-HIV-1 vaccines | Chemistry; Metallurgy | 0 | Active |
| US9024003B2 | Avian telomerase reverse transcriptase | Chemistry; Metallurgy | 0 | Active |
| US8778675B2 | Immortalized avian cell lines and use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US8445270B2 | Immortalized avian cell lines and use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.